CEFTAZIDIME, AVIBACTAM

CEFTAZIDIME, AVIBACTAM was reported 169 times

CEFTAZIDIME, AVIBACTAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIMICROBIAL SUSCEPTIBILITY TEST 1 0.1111
1 RADICAL CYSTECTOMY 2 0.0571
2 SCLEROTHERAPY 1 0.0217
3 BURKHOLDERIA TEST POSITIVE 1 0.0081
4 PROCEDURAL PNEUMOTHORAX 1 0.0065
5 ASPIRATION JOINT 1 0.0050
6 ANORECTAL INFECTION 1 0.0040
7 ATRIAL ENLARGEMENT 1 0.0037
8 THERAPEUTIC EMBOLISATION 1 0.0032
9 KLEBSIELLA TEST POSITIVE 2 0.0031
10 SOFT TISSUE NECROSIS 2 0.0029
11 PRODUCT NAME CONFUSION 3 0.0027
12 DISEASE RISK FACTOR 1 0.0025
13 GINGIVAL DISCOLOURATION 1 0.0019
14 POST PROCEDURAL INFLAMMATION 1 0.0016
15 INTERCEPTED PRODUCT SELECTION ERROR 2 0.0015
16 PNEUMONIA PSEUDOMONAL 2 0.0013
17 QRS AXIS ABNORMAL 1 0.0013
18 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
19 CATHETER SITE PRURITUS 1 0.0011
20 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
21 PRODUCT STORAGE ISSUE 4 0.0011
22 INTUSSUSCEPTION 1 0.0010
23 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
24 NASAL INFLAMMATION 1 0.0009
25 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
26 GLUCOSE URINE PRESENT 1 0.0008
27 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
28 MULTIPLE-DRUG RESISTANCE 2 0.0006
29 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
30 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
31 EXTRAVASATION 2 0.0005
32 CATHETER SITE ERYTHEMA 1 0.0005
33 DRUG RESISTANCE 12 0.0005
34 LACUNAR INFARCTION 1 0.0004
35 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
36 AORTIC ARTERIOSCLEROSIS 1 0.0004
37 EAR CONGESTION 1 0.0004
38 CYSTIC FIBROSIS 2 0.0004
39 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
40 TOOTH DISCOLOURATION 1 0.0003
41 CENTRAL VENOUS CATHETERISATION 1 0.0003
42 PATHOGEN RESISTANCE 3 0.0003
43 NON-CARDIAC CHEST PAIN 1 0.0003
44 ASPERGILLUS INFECTION 2 0.0003
45 SKIN WEEPING 1 0.0003
46 MENTAL STATUS CHANGES 7 0.0003
47 TONGUE DISCOMFORT 1 0.0002
48 INTERVERTEBRAL DISC DISORDER 1 0.0002
49 PRODUCT DISPENSING ISSUE 1 0.0002
50 HYSTERECTOMY 2 0.0002
51 LUNG INFILTRATION 2 0.0002
52 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
53 HAEMOLYTIC ANAEMIA 2 0.0002
54 ISCHAEMIA 1 0.0002
55 ARTHRITIS INFECTIVE 1 0.0002
56 KLEBSIELLA INFECTION 1 0.0002
57 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
58 EXERCISE TOLERANCE DECREASED 1 0.0002
59 PRODUCT STORAGE ERROR 15 0.0002
60 COVID-19 PNEUMONIA 2 0.0002
61 MYOCLONUS 2 0.0002
62 ENCEPHALOPATHY 4 0.0002
63 INFUSION SITE EXTRAVASATION 1 0.0002
64 INFUSION SITE SWELLING 1 0.0002
65 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
66 PRODUCT PREPARATION ISSUE 1 0.0002
67 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
68 BRONCHIECTASIS 1 0.0001
69 PRODUCT LABEL ISSUE 1 0.0001
70 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
71 RESPIRATORY FAILURE 9 0.0001
72 SHOCK HAEMORRHAGIC 1 0.0001
73 POLYURIA 1 0.0001
74 PRODUCT CONTAINER ISSUE 1 0.0001
75 SKIN HYPERPIGMENTATION 1 0.0001
76 PRODUCT DISTRIBUTION ISSUE 1 0.0001
77 ATELECTASIS 1 0.0001
78 PRODUCT ADMINISTRATION ERROR 2 0.0001
79 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
80 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
81 LIVER FUNCTION TEST INCREASED 2 0.0001
82 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
83 SEPTIC SHOCK 4 0.0001
84 PRODUCT DISPENSING ERROR 2 0.0001
85 STEVENS-JOHNSON SYNDROME 2 0.0001
86 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
87 STATUS EPILEPTICUS 1 0.0001
88 BACTERAEMIA 1 0.0001
89 NOCTURIA 1 0.0001
90 SPINAL OPERATION 1 0.0001
91 INJECTION SITE EXTRAVASATION 1 0.0001
92 GENERALISED OEDEMA 1 0.0001
93 SECRETION DISCHARGE 1 0.0001
94 DERMATITIS ALLERGIC 1 0.0001
95 HAND DEFORMITY 1 0.0001
96 SINUS CONGESTION 1 0.0001
97 SINUS TACHYCARDIA 1 0.0001
98 MYELODYSPLASTIC SYNDROME 1 0.0001
99 RENAL INJURY 2 0.0001
100 DRUG DISPENSING ERROR 1 0.0001
101 HIP ARTHROPLASTY 1 0.0001
102 CANDIDA INFECTION 1 0.0001
103 THERAPY CESSATION 3 0.0001
104 DELIRIUM 2 0.0001
105 LEUKOCYTOSIS 1 0.0001
106 HEPATIC CIRRHOSIS 1 0.0001
107 FRACTURE 1 0.0001
108 BLOOD URINE PRESENT 1 0.0001
109 ACUTE KIDNEY INJURY 8 0.0001
110 CHOLESTASIS 1 0.0001
111 GLAUCOMA 1 0.0001
112 ERUCTATION 1 0.0001
113 PREGNANCY 1 0.0000
114 PRODUCT PREPARATION ERROR 1 0.0000
115 MOUTH ULCERATION 1 0.0000
116 RECTAL HAEMORRHAGE 2 0.0000
117 PRODUCT PRESCRIBING ISSUE 1 0.0000
118 MELAENA 1 0.0000
119 TRANSAMINASES INCREASED 1 0.0000
120 CHROMATURIA 1 0.0000
121 HEPATIC ENZYME INCREASED 3 0.0000
122 PRODUCT AVAILABILITY ISSUE 1 0.0000
123 RASH ERYTHEMATOUS 2 0.0000
124 HEPATIC CANCER 1 0.0000
125 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
126 PNEUMONIA ASPIRATION 1 0.0000
127 HEPATITIS 1 0.0000
128 OFF LABEL USE 34 0.0000
129 RASH GENERALISED 1 0.0000
130 JAUNDICE 1 0.0000
131 BLOOD BILIRUBIN INCREASED 1 0.0000
132 RASH PRURITIC 2 0.0000
133 PALLOR 1 0.0000
134 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
135 RESPIRATORY DISTRESS 1 0.0000
136 HAEMOPTYSIS 1 0.0000
137 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
138 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
139 HYPOTENSION 7 0.0000
140 SEIZURE 4 0.0000
141 LIVER FUNCTION TEST ABNORMAL 1 0.0000
142 APHASIA 1 0.0000
143 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
144 LIMB DISCOMFORT 1 0.0000
145 DRUG-INDUCED LIVER INJURY 1 0.0000
146 LACTIC ACIDOSIS 1 0.0000
147 FUNGAL INFECTION 1 0.0000
148 NEOPLASM MALIGNANT 2 0.0000
149 CHEST DISCOMFORT 3 0.0000
150 HYPERKALAEMIA 1 0.0000
151 HYPOXIA 1 0.0000
152 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
153 C-REACTIVE PROTEIN INCREASED 1 0.0000
154 HYPERGLYCAEMIA 1 0.0000
155 DYSURIA 1 0.0000
156 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
157 DYSKINESIA 1 0.0000
158 LUNG NEOPLASM MALIGNANT 1 0.0000
159 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
160 CARDIO-RESPIRATORY ARREST 1 0.0000
161 HYPOACUSIS 1 0.0000
162 MENTAL DISORDER 1 0.0000
163 INTENTIONAL PRODUCT MISUSE 2 0.0000
164 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
165 TINNITUS 1 0.0000
166 SKIN DISCOLOURATION 1 0.0000
167 MULTIPLE SCLEROSIS 1 0.0000
168 HYPOGLYCAEMIA 1 0.0000
169 PYREXIA 7 0.0000
170 DRY EYE 1 0.0000
171 CELLULITIS 1 0.0000
172 CONFUSIONAL STATE 3 0.0000
173 OEDEMA 1 0.0000
174 TREATMENT NONCOMPLIANCE 1 0.0000
175 ANAPHYLACTIC REACTION 1 0.0000
176 SEPSIS 2 0.0000
177 PANCYTOPENIA 1 0.0000
178 THROMBOCYTOPENIA 2 0.0000
179 HYPONATRAEMIA 1 0.0000
180 MUSCULAR WEAKNESS 2 0.0000
181 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
182 ABDOMINAL PAIN 4 0.0000
183 CATARACT 1 0.0000
184 JOINT SWELLING 2 0.0000
185 PLEURAL EFFUSION 1 0.0000
186 OEDEMA PERIPHERAL 2 0.0000
187 PNEUMONIA 5 0.0000
188 BLOOD CREATININE INCREASED 1 0.0000
189 FEBRILE NEUTROPENIA 1 0.0000
190 THERAPY INTERRUPTED 1 0.0000
191 SKIN BURNING SENSATION 1 0.0000
192 AGITATION 1 0.0000
193 PERIPHERAL SWELLING 2 0.0000
194 THROMBOSIS 1 0.0000
195 DRY MOUTH 1 0.0000
196 INFLUENZA LIKE ILLNESS 1 0.0000
197 CARDIAC ARREST 1 0.0000
198 URINARY TRACT INFECTION 2 0.0000
199 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
200 COVID-19 2 0.0000
201 NO ADVERSE EVENT 2 0.0000
202 SWELLING 1 0.0000
203 DYSPNOEA 6 0.0000
204 DYSPHAGIA 1 0.0000
205 NEUROPATHY PERIPHERAL 1 0.0000
206 ATRIAL FIBRILLATION 1 0.0000
207 HEART RATE INCREASED 1 0.0000
208 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
209 SINUSITIS 1 0.0000
210 HAEMOGLOBIN DECREASED 1 0.0000
211 ILLNESS 1 0.0000
212 HEADACHE 6 0.0000
213 HAEMORRHAGE 1 0.0000
214 OVERDOSE 2 0.0000
215 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
216 CONSTIPATION 2 0.0000
217 WEIGHT INCREASED 2 0.0000
218 INCORRECT DOSE ADMINISTERED 2 0.0000
219 CHILLS 1 0.0000
220 VISUAL IMPAIRMENT 1 0.0000
221 NAUSEA 6 0.0000
222 RENAL FAILURE 1 0.0000
223 DRY SKIN 1 0.0000
224 PRODUCT QUALITY ISSUE 1 0.0000
225 NEUTROPENIA 1 0.0000
226 COUGH 2 0.0000
227 DEATH 6 0.0000
228 INFECTION 1 0.0000
229 MALAISE 3 0.0000
230 BLOOD PRESSURE INCREASED 1 0.0000
231 PAIN 4 0.0000
232 HOSPITALISATION 1 0.0000
233 VOMITING 3 0.0000
234 DIZZINESS 3 0.0000
235 CHEST PAIN 1 0.0000
236 HYPERSENSITIVITY 1 0.0000
237 GAIT DISTURBANCE 1 0.0000
238 PRURITUS 2 0.0000
239 FATIGUE 4 0.0000
240 SOMNOLENCE 1 0.0000
241 ERYTHEMA 1 0.0000
242 HYPERTENSION 1 0.0000
243 DIARRHOEA 3 0.0000
244 DECREASED APPETITE 1 0.0000
245 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
246 DRUG INEFFECTIVE 5 0.0000
247 INSOMNIA 1 0.0000
248 WEIGHT DECREASED 1 0.0000
249 PRODUCT DOSE OMISSION ISSUE 1 0.0000
250 FALL 1 0.0000
251 ARTHRALGIA 1 0.0000
252 RASH 1 0.0000